Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data ...

The US Food and Drug Administration on Wednesday approved a cancer drug developed by China-based Akeso Inc, marking a ...

Reckitt Benckiser's CEO, Kris Licht, highlighted India as a key growth driver, anticipating sustained strong volume growth ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...

Where thousands of former Health and Human Services employees will work next is unknown, but biopharma companies likely ...

EUDA Health Holdings Limited ('EUDA” or the 'Company”) (NASDAQ: EUDA), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, ...

As global trade tensions escalate, the United States may benefit from applying the concept of precision medicine to ...

Sakshi holds a BSc in Biotechnology from the University of Birmingham and an MBA from The Wharton School. She began her ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

The US National Security Commission on Emerging Biotechnology has warned China is in a position to create practically ...

While Intuitive is still reporting steady growth in the placement of its da Vinci surgical robots—as well as the number of ...

The firm also reported its Life Sciences segment revenues fell 4 percent in the quarter, while Diagnostics revenues decreased 3 percent.